Arctigenin derivative A‐1 ameliorates motor dysfunction and pathological manifestations in <scp>SOD1<sup>G93A</sup></scp> transgenic mice via the <scp>AMPK</scp>/<scp>SIRT1</scp>/<scp>PGC</scp>‐1α and <scp>AMPK</scp>/<scp>SIRT1</scp>/<scp>IL</scp>‐1β/<scp>NF‐κB</scp> pathways
2024 · CNS Neuroscience & Therapeutics · 16 citations
https://doi.org/10.1111/cns.14692